Sánchez-Pérez Ana María, Llansola Marta, Felipo Vicente
Laboratory of Neurobiology, Centro de Investigación Príncipe Felipe, Valencia, Spain.
Neurochem Int. 2006 Sep;49(4):351-8. doi: 10.1016/j.neuint.2006.02.005. Epub 2006 Apr 18.
The aim of the present work was to assess whether Akt modulates NMDA receptor function in cerebellar neurons in culture. Forskolin increases cAMP and activates Akt and NMDA receptors. In neurons treated with forskolin, intracellular calcium increased to 296 +/- 38% and this was completely prevented by inhibition of Akt. This indicates that, in these neurons, cAMP modulates NMDA receptors via Epac and Akt. Brain derived neurotrophic factor (BDNF) increases phosphorylation (and activity) of Akt to 350 +/- 60% of basal and also potentiates the increase of calcium and in cGMP induced by NMDA. BDNF-induced potentiation of NMDA receptor function is completely prevented by inhibition of PI3 kinase or of Akt. This indicates that BDNF modulates NMDA receptor function via PI3 kinase and Akt. Activation of NMDA receptors also leads to phosphorylation and activation of Akt which, in turn, potentiates NMDA receptor activation. The results reported indicate that when Akt activity increases the activation of NMDA receptors by its agonists also increases. Akt may play important roles in the modulation of NMDA receptor responses by other neurotransmitters and modulators and in the adaptation of NMDA receptor function to the physiological environmental conditions.
本研究的目的是评估Akt是否调节培养的小脑神经元中NMDA受体的功能。福斯高林可增加cAMP并激活Akt和NMDA受体。在用福斯高林处理的神经元中,细胞内钙增加至296±38%,而抑制Akt可完全阻止这种增加。这表明,在这些神经元中,cAMP通过Epac和Akt调节NMDA受体。脑源性神经营养因子(BDNF)可使Akt的磷酸化(及活性)增加至基础水平的350±60%,并增强NMDA诱导的钙增加及cGMP增加。抑制PI3激酶或Akt可完全阻止BDNF诱导的NMDA受体功能增强。这表明BDNF通过PI3激酶和Akt调节NMDA受体功能。NMDA受体的激活也会导致Akt的磷酸化和激活,进而增强NMDA受体的激活。报道的结果表明,当Akt活性增加时,其激动剂对NMDA受体的激活也会增加。Akt可能在其他神经递质和调节剂对NMDA受体反应的调节以及NMDA受体功能对生理环境条件的适应中发挥重要作用。